EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Somatic Evolution of a Germline Antibody Expands its Breadth to Neutralize Early SARS‐CoV‐2 Omicron Variants

Huibin Lv iD, Ziqi Feng, Qi Wen Teo, Chunke Chen, Akshita B Gopal, Danbi Choi, Timothy J C Tan, Yun Sang Tang, Lewis Siu, Armita Nourmohammad, Roberto Bruzzone, Ian A Wilson und 3 weitere

Advanced Science · 13.07.2026

DOI: 10.1002/advs.76522 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 13.07.2026. Verfasst von Huibin Lv und 14 weiteren Autor:innen. Beteiligte Einrichtung: Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Calmette and Yersin scholarship from the Pasteur International Network Association, Carl R. Woese Institute for Genomic Biology (IGB) postdoctoral fellowship, Research Grants Council of the Hong Kong Special Administrative Region, China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid antigenic drift of the SARS‐CoV‐2 receptor‐binding domain (RBD) underlies immune escape and continues to challenge the durability of antibody‐mediated protection. Among the major classes of RBD‐directed antibodies, germline‐encoded IGHV3‐53 responses are highly potent against early SARS‐CoV‐2 variants but are generally compromised by Omicron‐associated mutations. Here, we identify an intrinsically cross‐reactive IGHV3‐53 germline antibody that recognizes multiple pre‐Omicron variants, including SARS‐CoV‐2 wild‐type, Alpha, and Delta. Notably, we demonstrate that targeted somatic evolution can further expand this breadth to overcome the immune escape of different Omicron variants. Guided by integrated structural and sequence analyses, we introduce four somatic mutations (G26E, T28I, S53P, and Y58F) into the germline antibody, resulting in markedly enhanced binding and neutralization of Omicron BA.1, and BA.4/5. High‐resolution crystal structures reveal that these mutations re‐establish interactions disrupted by substitutions in the Omicron RBD and improve binding at a remodeled epitope interface. Collectively, our findings define the structural basis by which specific mutations enhance cross‐variant recognition of SARS‐CoV‐2. This work highlights the underappreciated breadth encoded within the naïve B‐cell repertoire and provides a conceptual framework for engineering and eliciting antibody responses resilient to future antigenic drift.

Autor:innen und Institutionen

  • Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
  • Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
  • HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
  • The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

ORCID-Profile: Huibin Lv

Förderung

  • Calmette and Yersin scholarship from the Pasteur International Network Association
  • Carl R. Woese Institute for Genomic Biology (IGB) postdoctoral fellowship
  • Research Grants Council of the Hong Kong Special Administrative Region, China
  • Health and Medical Research Fund
  • Vallee Scholars Program
  • Searle Scholars Program
  • Howard Hughes Medical Institute Emerging Pathogens Initiative

Zitieren

APA

Lv, H., Feng, Z., Teo, Q. W., Chen, C., Gopal, A. B., Choi, D., Tan, T. J. C., Tang, Y. S., Siu, L., Nourmohammad, A., Bruzzone, R., Wilson, I. A., Yuan, M., Wu, N. C., & Mok, C. K. P. (2026). Somatic Evolution of a Germline Antibody Expands its Breadth to Neutralize Early SARS‐CoV‐2 Omicron Variants. Advanced Science. https://doi.org/10.1002/advs.76522

Vancouver

Lv H, Feng Z, Teo QW, Chen C, Gopal AB, Choi D, et al. Somatic Evolution of a Germline Antibody Expands its Breadth to Neutralize Early SARS‐CoV‐2 Omicron Variants. Advanced Science. 2026. doi:10.1002/advs.76522

BibTeX
@article{Lv2026,
  author = {Lv, Huibin and Feng, Ziqi and Teo, Qi Wen and Chen, Chunke and Gopal, Akshita B and Choi, Danbi and Tan, Timothy J C and Tang, Yun Sang and Siu, Lewis and Nourmohammad, Armita and Bruzzone, Roberto and Wilson, Ian A and Yuan, Meng and Wu, Nicholas C and Mok, Chris K P},
  title = {Somatic Evolution of a Germline Antibody Expands its Breadth to Neutralize Early SARS‐CoV‐2 Omicron Variants},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76522}
}
Kostenlos starten →